x, Identified acetylated lysines. Each “x” indicates that the modification was identified and multiple “x’s” indicate that the modification was identified by the corresponding number of replicates. For example, “xx” indicates that the modification was identified in 2 replicates. [ ] Number of replicates. Abbreviations: Ins, insulin; AICAR, 5-aminoimidazole-4-carboxamide riboside; cAMP, dibutyryl-cyclic adenosine monophosphate; Iso, isoproterenol; Fors, forskolin; CL, CL-316243; di8,1,2-dioctanoyl-sn-glycerol Note: ACSL1 was immunopurified from samples using RIPA buffer. Some of the untreated liver and brown adipocyte immunopurifications were done with gentle lysis buffer |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Table 1: Acetylation sites found in overexpressed ACSL1. Ad-Acsl1-Flag was overexpressed in rat hepatocytes, mouse brown adipocytes or 3T3-L1 adipocytes, and treated as indicated. |